Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=208"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=208

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00274261-1cfcf389",
        "title": "C31G Vaginal Gel vs Conceptrol® Vaginal Gel: Incidence of Adverse Events.",
        "summary": "617 of 932 against 434 of 633; risk difference -2.4 points, 95% interval -7.0 to 2.4; NCT00274261, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®",
        "record": "/library/comparisons/NCT00274261-1cfcf389",
        "nct_id": "NCT00274261",
        "kind": "outcome",
        "participants": 1565,
        "risk_difference": {
          "value": -0.023606845256256448,
          "lower": -0.07031391634254242,
          "upper": 0.023958727873519707
        },
        "group_1": "617 of 932",
        "group_2": "434 of 633",
        "difference": "-2.4 points",
        "interval": "-7.0 to 2.4",
        "trial_title": "Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®"
      },
      {
        "id": "NCT02079246-deaths",
        "title": "Idalopirdine 60 mg vs Idalopirdine 60 mg + Memantine: deaths from any cause",
        "summary": "11 of 1462 against 0 of 101; risk difference 0.8 points, 95% interval -2.9 to 1.3; NCT02079246, Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease",
        "record": "/library/comparisons/NCT02079246-deaths",
        "nct_id": "NCT02079246",
        "kind": "deaths",
        "participants": 1563,
        "risk_difference": {
          "value": 0.007523939808481532,
          "lower": -0.029266588509199422,
          "upper": 0.013422685523653558
        },
        "group_1": "11 of 1,462",
        "group_2": "0 of 101",
        "difference": "0.8 points",
        "interval": "-2.9 to 1.3",
        "trial_title": "Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=209",
  "request_id": "AwtQLs1CgQf8mtEu"
}